AU2007300197A1 - A method of administering a film product containing a drug - Google Patents

A method of administering a film product containing a drug Download PDF

Info

Publication number
AU2007300197A1
AU2007300197A1 AU2007300197A AU2007300197A AU2007300197A1 AU 2007300197 A1 AU2007300197 A1 AU 2007300197A1 AU 2007300197 A AU2007300197 A AU 2007300197A AU 2007300197 A AU2007300197 A AU 2007300197A AU 2007300197 A1 AU2007300197 A1 AU 2007300197A1
Authority
AU
Australia
Prior art keywords
film
polyethylene oxide
water
product
polymer composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007300197A
Other languages
English (en)
Inventor
Richard C. Fuisz
Garry L. Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aquestive Therapeutics Inc
Original Assignee
MonoSol Rx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MonoSol Rx LLC filed Critical MonoSol Rx LLC
Publication of AU2007300197A1 publication Critical patent/AU2007300197A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2007300197A 2006-09-26 2007-09-25 A method of administering a film product containing a drug Abandoned AU2007300197A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/526,996 2006-09-26
US11/526,996 US20080050422A1 (en) 2001-10-12 2006-09-26 Method of administering a film product containing a drug
PCT/US2007/079357 WO2008039737A2 (en) 2006-09-26 2007-09-25 A method of administering a film product containing a drug

Publications (1)

Publication Number Publication Date
AU2007300197A1 true AU2007300197A1 (en) 2008-04-03

Family

ID=39166452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007300197A Abandoned AU2007300197A1 (en) 2006-09-26 2007-09-25 A method of administering a film product containing a drug

Country Status (7)

Country Link
US (1) US20080050422A1 (enExample)
EP (1) EP2079457A2 (enExample)
JP (1) JP2010504993A (enExample)
CN (1) CN101534803A (enExample)
AU (1) AU2007300197A1 (enExample)
CA (1) CA2664669A1 (enExample)
WO (1) WO2008039737A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100753959B1 (ko) * 2006-01-12 2007-08-31 에이펫(주) 기판 건조장치를 이용한 기판 건조방법
JP4916894B2 (ja) * 2007-01-11 2012-04-18 株式会社ツキオカ フィルム状製剤及びフィルム状製剤の製造方法
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine
US8623401B2 (en) * 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
KR101866189B1 (ko) * 2008-08-25 2018-06-11 규큐 야쿠힝 고교 가부시키가이샤 로페라마이드 염산염 함유 필름 제제
PT2952191T (pt) 2009-06-12 2018-11-30 Sunovion Pharmaceuticals Inc Apomorfina sublingual
EP2448553A2 (en) * 2009-06-30 2012-05-09 Dow Global Technologies LLC Sunscreen-containing dissolvable films comprising water-soluble cellulose ether
TR201902233T4 (tr) * 2009-10-30 2019-03-21 Ix Biopharma Ltd Hızlı çözünen katı dozaj formu.
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
CN102048711B (zh) * 2009-11-11 2013-06-05 河北奥星集团药业有限公司 一种格拉司琼膜制剂及其制备方法
AU2010343147A1 (en) 2009-12-28 2012-07-19 Monosol Rx, Llc Orally administrable film dosage forms containing ondansetron
WO2011081625A1 (en) * 2009-12-30 2011-07-07 Novartis Ag Melt extruded thin strips containing coated pharmaceutical actives
JP6050564B2 (ja) * 2010-03-11 2016-12-21 テイカ製薬株式会社 フィルム状製剤
CN102440979A (zh) * 2010-09-30 2012-05-09 迪特克(济源)绿色生物科技有限公司 一种纤维素衍生物复合膜及其制备方法
EP2651357B1 (en) 2010-12-16 2020-04-01 Sunovion Pharmaceuticals Inc. Sublingual films
US11129799B2 (en) 2011-04-12 2021-09-28 Aquestive Therapeutics, Inc. Dual lane coating
US9993422B2 (en) 2012-04-18 2018-06-12 SpecGx LLC Immediate release, abuse deterrent pharmaceutical compositions
HUE065006T2 (hu) 2014-07-03 2024-04-28 SpecGx LLC Nem-cellulóz poliszacharidokat tartalmazó, visszaélés-gátló, azonnali felszabadulású készítmények
US20160220480A1 (en) * 2015-02-03 2016-08-04 Intelgenx Corp. Oral dosage film exhibiting enhanced mucosal penetration
EP4578461A3 (en) 2015-04-21 2025-09-03 Sumitomo Pharma America, Inc. Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
JP2018197216A (ja) * 2017-05-24 2018-12-13 株式会社プラスアルファー フィルムシート状栄養剤
JP6842998B2 (ja) * 2017-05-30 2021-03-17 日清ファルマ株式会社 コエンザイムｑ１０フィルム製剤
DE102018101778A1 (de) * 2018-01-26 2019-08-01 Lts Lohmann Therapie-Systeme Ag Mehrschichtiger Oraler Dünnfilm
WO2020006073A1 (en) 2018-06-28 2020-01-02 Arx, Llc Dispensing method for producing dissolvable unit dose film constructs
WO2020014776A1 (en) * 2018-07-15 2020-01-23 Rapid Dose Therapeutics Corp. Cannabinoid oral dispersible film strip
WO2020068510A1 (en) 2018-09-25 2020-04-02 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
EP3895692A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Oral thin film with smooth fused film
EP3895691A1 (en) * 2020-04-15 2021-10-20 LTS Lohmann Therapie-Systeme AG Ulipristal acetate otf

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery
US7666337B2 (en) * 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
BR0206473A (pt) * 2001-11-16 2003-12-30 Givaudan Sa Pelìcula comestìvel
JP2003213038A (ja) * 2001-11-16 2003-07-30 Natl Starch & Chem Investment Holding Corp デンプンを含有するフィルム
KR20110004921A (ko) * 2002-05-16 2011-01-14 규큐 야쿠힝 고교 가부시키가이샤 속용성 필름형상 제제
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
AU2004319243B2 (en) * 2003-05-28 2010-06-03 Aquestive Therapeutics, Inc. Polyethylene oxide-based films and drug delivery systems made therefrom
CA2581851C (en) * 2004-09-30 2016-11-01 Monosolrx Llc Multi-layer films having uniform content

Also Published As

Publication number Publication date
EP2079457A2 (en) 2009-07-22
US20080050422A1 (en) 2008-02-28
WO2008039737A2 (en) 2008-04-03
CA2664669A1 (en) 2008-04-03
CN101534803A (zh) 2009-09-16
WO2008039737A3 (en) 2008-05-22
JP2010504993A (ja) 2010-02-18

Similar Documents

Publication Publication Date Title
US7824588B2 (en) Method of making self-supporting therapeutic active-containing film
CA2544776C (en) Polyethylene oxide-based films and drug delivery systems made therefrom
US9108340B2 (en) Process for manufacturing a resulting multi-layer pharmaceutical film
US8017150B2 (en) Polyethylene oxide-based films and drug delivery systems made therefrom
US7666337B2 (en) Polyethylene oxide-based films and drug delivery systems made therefrom
EP2351557B1 (en) Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom
US8900498B2 (en) Process for manufacturing a resulting multi-layer pharmaceutical film
CA2514897C (en) Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8900497B2 (en) Process for making a film having a substantially uniform distribution of components
US20080050422A1 (en) Method of administering a film product containing a drug
EP2167034A1 (en) Film shreds and delivery systems incorporating same
US20140070440A1 (en) Films and Drug Delivery Systems Made Therefrom
US20190105810A1 (en) Film and Drug Delivery System Made Therefrom
US20130220526A1 (en) Films and Drug Delivery Systems Made Therefrom
US20130333831A1 (en) Films and Drug Delivery Systems Made Therefrom
AU2012261557A1 (en) Polyethylene oxide-based films and drug delivery systems made therefrom
IE20030269A1 (en) Method for testing uniformity in a film manufacturing process
IE83877B1 (en) Method for testing uniformity in a film manufacturing process

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application